Local Institution - 005-125 — McKinney, Texas

Local Institution - 005-125 is a clinical research site located in McKinney, Texas, United States 75071.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 005-125 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Squamous Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in McKinney

Browse all research sites in Texas · View every site in McKinney

• Baylor Scott & White The Heart Hospital - Mckinney
• Research Site
• North Dallas Research Associates
• Metroplex Pulmonary and Sleep Center
• Texas Oncology-McKinney
• Texas Institute of Cardiology
• GSK Investigational Site
• Novartis Investigative Site
• Tekton Research
• ENT Associates of Texas
• Texas Institute of Cardiology PA
• North Texas Research Associates

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 005-125?

Local Institution - 005-125 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 005-125 conducted?

Local Institution - 005-125 has 1 clinical trials on record. Their work covers Metastatic Non-Squamous Non-Small Cell Lung Cancer.

Is Local Institution - 005-125 accredited by Crixeo Clinical Trials?

Local Institution - 005-125 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 005-125?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.